Q4 2014 13F Holders as of 12/31/2014
-
Type / Class
-
Equity / COM
-
Number of holders
-
14
-
Total 13F shares, excl. options
-
1.86M
-
Shares change
-
+634K
-
Total reported value, excl. options
-
$2.71M
-
Value change
-
+$928K
-
Number of buys
-
3
-
Number of sells
-
-4
-
Price
-
$1.46
Significant Holders of ProPhase Labs, Inc. - COM (PRPH) as of Q4 2014
15 filings reported holding PRPH - ProPhase Labs, Inc. - COM as of Q4 2014.
ProPhase Labs, Inc. - COM (PRPH) has 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.86M shares
.
Largest 10 shareholders include MORGAN STANLEY (682K shares), Vantage Investment Partners, LLC (438K shares), Bank of New York Mellon Corp (209K shares), DIMENSIONAL FUND ADVISORS LP (157K shares), VANGUARD GROUP INC (130K shares), PNC Financial Services Group, Inc. (60K shares), RENAISSANCE TECHNOLOGIES LLC (47.7K shares), CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM (47.4K shares), Citadel Advisors LLC (27.3K shares), and Commonwealth Equity Services, Inc (19.3K shares).
This table shows the top 14 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.